secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2026-06-15T21:06:05+00:00
Accession:  0001654954-26-005989
Event type: earnings
Sentiment:  positive
Materiality: 0.40
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q1 revenue $2.7M, net income $0.2M; both up YoY
---------------------------------------------------------------

- Three-month revenue $2.7M, up $0.3M vs prior year; net income $0.2M, up $0.1M.
- Six-month revenue $5.0M, up $0.1M; net income $0.3M, up $0.2M.
- CEO cites strategic focus on high-return markets and cost management for profit improvement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426005989/0001654954-26-005989-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495426005989/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-26-005989

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer